Ovarian cancer affects both the ovaries and is referred to as the ''silent killer'' as the symptoms go unnoticed until the disease advances.
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
New ovarian cancer target has been identified by experts at the Houston Methodist Cancer Center. Preclinical research shows that malignant cells are linked to supportive fibroblasts and they can be hit with Calcitriol.
Cellular pathway that selectively regulates a mutant protein, called p53-R175H, linked to ovarian cancer growth has been identified by a research team. This discovery opens the possibility of developing a novel way to fight ovarian cancer.